Evidence map›Paper›PMID 12885922›Full record

ArticleJournal of virology2003

Role of the human immunodeficiency virus type 1 envelope gene in viral fitness.

Hector R Rangel, Jan Weber, Bikram Chakraborty, Arantxa Gutierrez, Michael L Marotta, Muneer Mirza, Patti Kiser, Miguel A Martinez, Jose A Este, Miguel E Quiñones-Mateu

Abstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hector R RangelDepartment of Virology, Lerner Research Institute, Cleveland Clinic Foundation, OH 44195, USA.
Jan Weber
Bikram Chakraborty
Arantxa Gutierrez
Michael L Marotta
Muneer Mirza
Patti Kiser
Miguel A Martinez
Jose A Este
Miguel E Quiñones-Mateu

Funding

WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI CHERYL M CAMERON · 1994 to 2026
$50.0M
HIV EVOLUTION AND ROLE OF CHEMOKINES IN THE LUNGK01HL067610 · NHLBI · CLEVELAND CLINIC LERNER COL/MED-CWRU · PI QUINONES-MATEU, MIGUEL E · 2000 to 2004
$660k
NHLBI NIH HHS 5-K01-HL67610-03NHLBI NIH HHS K01 HL067610NIAID NIH HHS AI36219NIAID NIH HHS P30 AI036219
6 · The paper itself

Abstract

A human host offers a variety of microenvironments to the infecting human immunodeficiency virus type 1 (HIV-1), resulting in various selective pressures, most of them directed against the envelope (env) gene. Therefore, it seems evident that the replicative capacity of the virus is largely related to viral entry. In this study we have used growth competition experiments and TaqMan real-time PCR detection to measure the fitness of subtype B HIV-1 primary isolates and autologous env-recombinant viruses in order to analyze the contribution of wild-type env sequences to overall HIV-1 fitness. A significant correlation was observed between fitness values obtained for wild-type HIV-1 isolates and those for the corresponding env-recombinant viruses (r = 0.93; P = 0.002). Our results suggest that the env gene, which is linked to a myriad of viral characteristics (e.g., entry into the host cell, transmission, coreceptor usage, and tropism), plays a major role in fitness of wild-type HIV-1. In addition, this new recombinant assay may be useful for measuring the contribution of HIV-1 env to fitness in viruses resistant to novel antiretroviral entry inhibitors.

Indexed as

Genes, envBase SequenceDNA PrimersHIV-1Polymerase Chain ReactionDNA Primers

Identifiers

PMID12885922
PMCPMC167250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.